Cross-reactivity of influenza A (H3N2) hemagglutination-inhibition antibodies induced by an inactivated influenza vaccine

被引:16
作者
Kojimahara, Noriko [1 ]
Maeda, Akiko [1 ]
Kase, Tetsuo [1 ]
Yamaguchi, Naohito [1 ]
机构
[1] Tokyo Womens Med Univ, Dept Hyg & Publ Hlth 2, Shinjuku Ku, Tokyo 1628666, Japan
关键词
influenza vaccine; hemagglutination-inhibition antibody; elderly;
D O I
10.1016/j.vaccine.2006.05.009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The antigenic drift of influenza A (H3N2) virus in 2003-2004 necessitated a change in the vaccine from the A/Panama to the A/Wyoming strain for the 2004-2005 season. Using hemagglutination inhibition, we therefore tested antibodies in sera of 39 individuals (mean age 64.6 years) at the end of the 2003-2004 season for cross-reactivity to vaccine strains and H3N2 antigens subject to antigenic drift. Antibodies against both A (H3N2) Panama and Wyoming developed in 5/13 (38.5%) unvaccinated individuals, whereas, 22/26 (84.6%) vaccinees developed antibodies to Panama and 21/26 (80.8%) to Wyoming. None of these individuals suffered an influenza episode that season. The results suggest that the elderly might develop protective levels of cross-reactive A (H3N2) Wyoming HI antibodies following vaccination with the Panama strain. Such strains, like the ones included in the 2003-2004 influenza vaccine, might be expected to provide a broad-spectrum antibody response that could be effective even in the face of single season antigenic drift. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5966 / 5969
页数:4
相关论文
共 16 条
[1]  
Tablan Ofelia C, 2004, MMWR Recomm Rep, V53, P1
[2]   The age-associated decline in immune function of healthy individuals is not related to changes in plasma concentrations of beta-carotene, retinol, alpha-tocopherol or zinc [J].
Gardner, EM ;
Bernstein, ED ;
Dorfman, M ;
Abrutyn, E ;
Murasko, DM .
MECHANISMS OF AGEING AND DEVELOPMENT, 1997, 94 (1-3) :55-69
[3]   THE EFFICACY OF INFLUENZA VACCINE IN ELDERLY PERSONS - A METAANALYSIS AND REVIEW OF THE LITERATURE [J].
GROSS, PA ;
HERMOGENES, AW ;
SACKS, HS ;
LAU, J ;
LEVANDOWSKI, RA .
ANNALS OF INTERNAL MEDICINE, 1995, 123 (07) :518-527
[4]   The hemagglutination inhibition antibody responses to an inactivated influenza vaccine among healthy adults: With special reference to the prevaccination antibody and its interaction with age [J].
Hirota, Y ;
Kaji, M ;
Ide, S ;
Goto, S ;
Oka, T .
VACCINE, 1996, 14 (17-18) :1597-1602
[5]   Antibody efficacy as a keen index to evaluate influenza vaccine effectiveness [J].
Hirota, Y ;
Kaji, M ;
Ide, S ;
Kajiwara, J ;
Kataoka, K ;
Goto, S ;
Oka, T .
VACCINE, 1997, 15 (09) :962-967
[6]  
KOJIMAHARA N, 2004, IGAKUNOAYUMI, V211, P1088
[7]  
KOLBOURNE ED, 1987, INFLUENZA
[8]  
LENETTE EH, 1979, HEMAGGLITINATION INH, P603
[9]  
MAEDA A, 2005, SOGO RINSHO, V54, P305
[10]   INFLUENZA VACCINATION PROGRAMS FOR ELDERLY PERSONS - COST-EFFECTIVENESS IN A HEALTH MAINTENANCE ORGANIZATION [J].
MULLOOLY, JP ;
BENNETT, MD ;
HORNBROOK, MC ;
BARKER, WH ;
WILLIAMS, WW ;
PATRIARCA, PA ;
RHODES, PH .
ANNALS OF INTERNAL MEDICINE, 1994, 121 (12) :947-952